The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Modulating immunity as a therapy for bacterial infections
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Self-citationThe Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., & Sansonetti, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200651200 · Cited by 2,408
Self-citationPathogen Recognition by the Innate Immune System
Kumar, H., Kawai, T., & Akira, S. (2011) · International Reviews of Immunology · doi:10.3109/08830185.2010.529976 · Cited by 2,257
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910
Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2
Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200673200 · Cited by 1,696
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
STING is a direct innate immune sensor of cyclic di-GMP
Burdette, D. L., Monroe, K. M., Sotelo-Troha, K., Iwig, J. S., Eckert, B., Hyodo, M., Hayakawa, Y., & Vance, R. E. (2011) · Nature · doi:10.1038/nature10429 · Cited by 1,570
Cooperation of Toll-like receptor signals in innate immune defence
Trinchieri, G., & Sher, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2038 · Cited by 1,364
Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide
Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S.-G., Lee, H., & Lee, J.-O. (2007) · Cell · doi:10.1016/j.cell.2007.09.008 · Cited by 1,344
Endotoxin tolerance: new mechanisms, molecules and clinical significance
Biswas, S. K., & Lopez-Collazo, E. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.009 · Cited by 1,318
Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2297 · Cited by 1,062
Bacterial Small-Molecule Signaling Pathways
Camilli, A., & Bassler, B. L. (2006) · Science · doi:10.1126/science.1121357 · Cited by 977
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Targeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
Woodward, J. J., Iavarone, A. T., & Portnoy, D. A. (2010) · Science · doi:10.1126/science.1189801 · Cited by 810
Shifting the balance: antibiotic effects on host–microbiota mutualism
Willing, B. P., Russell, S. L., & Finlay, B. B. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2536 · Cited by 747
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
Self-citationThe perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain
Choe, J., Kelker, M. S., & Wilson, I. A. (2005) · Science · doi:10.1126/science.1115253 · Cited by 602
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Martineau, A. R., Timms, P. M., Bothamley, G. H., Hanifa, Y., Islam, K., Claxton, A. P., Packe, G. E., Moore-Gillon, J. C., Darmalingam, M., Davidson, R. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61889-2 · Cited by 580
Brackman, G., Cos, P., Maes, L., Nelis, H. J., & Coenye, T. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00045-11 · Cited by 561
Sauer, J.-D., Sotelo-Troha, K., von Moltke, J., Monroe, K. M., Rae, C. S., Brubaker, S. W., Hyodo, M., Hayakawa, Y., Woodward, J. J., Portnoy, D. A., et al. (2011) · Infection and Immunity · doi:10.1128/iai.00999-10 · Cited by 539
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Wells, J. M., & Mercenier, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1840 · Cited by 537
Dupaul-Chicoine, J., Yeretssian, G., Doiron, K., Bergstrom, K. S. B., McIntire, C. R., LeBlanc, P. M., Meunier, C., Turbide, C., Gros, P., Beauchemin, N., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.02.012 · Cited by 517
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
Rice, T. W., Wheeler, A. P., Bernard, G. R., Vincent, J.-L., Angus, D. C., Aikawa, N., Demeyer, I., Sainati, S., Amlot, N., Cao, C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e7c5c9 · Cited by 512
Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis
Zaph, C., Troy, A. E., Taylor, B. C., Berman-Booty, L. D., Guild, K. J., Du, Y., Yost, E. A., Gruber, A. D., May, M. J., Greten, F. R., et al. (2007) · Nature · doi:10.1038/nature05590 · Cited by 496
Wu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446
An anti-infective peptide that selectively modulates the innate immune response
Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1288 · Cited by 403
Self-citationHigh-throughput generation of small antibacterial peptides with improved activity
Hilpert, K., Volkmer-Engert, R., Walter, T., & Hancock, R. E. W. (2005) · Nature Biotechnology · doi:10.1038/nbt1113 · Cited by 375
Self-citationProbiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2
Schlee, M., Harder, J., Köten, B., Stange, E. F., Wehkamp, J., & Fellermann, K. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03587.x · Cited by 359
Mechanism of action of clinically approved adjuvants
Lambrecht, B. N., Kool, M., Willart, M. A., & Hammad, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.004 · Cited by 354
Smith, R. S., Harris, S. G., Phipps, R., & Iglewski, B. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1132-1139.2002 · Cited by 351
In vitro and In vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37
Carretero, M., Escámez, M. J., García, M., Duarte, B., Holguín, A., Retamosa, L., Jorcano, J. L., Río, M. D., & Larcher, F. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701043 · Cited by 345
Fritz, J. H., Le Bourhis, L., Sellge, G., Magalhaes, J. G., Fsihi, H., Kufer, T. A., Collins, C., Viala, J., Ferrero, R. L., Girardin, S. E., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.009 · Cited by 331
Self-citationRaqib, R., Sarker, P., Bergman, P., Ara, G., Lindh, M., Sack, D. A., Nasirul Islam, K. M., Gudmundsson, G. H., Andersson, J., & Agerberth, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602888103 · Cited by 317
Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F., & Fellermann, K. (2007) · Infection and Immunity · doi:10.1128/iai.01563-06 · Cited by 315
Therapeutics targeting the innate immune system
Ulevitch, R. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1396 · Cited by 309
Advances in the assessment and control of the effector functions of therapeutic antibodies
Jiang, X.-R., Song, A., Bergelson, S., Arroll, T., Parekh, B., May, K., Chung, S., Strouse, R., Mire-Sluis, A., & Schenerman, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3365 · Cited by 299
Cosseau, C., Devine, D. A., Dullaghan, E., Gardy, J. L., Chikatamarla, A., Gellatly, S., Yu, L. L., Pistolic, J., Falsafi, R., Tagg, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.00188-08 · Cited by 293
Self-citationAntonelli, L. R. V., Gigliotti Rothfuchs, A., Gonçalves, R., Roffê, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292
Sensing damage by the NLRP3 inflammasome
Leemans, J. C., Cassel, S. L., & Sutterwala, F. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01043.x · Cited by 281
Braff, M. H., Hawkins, M. A., Nardo, A. D., Lopez-Garcia, B., Howell, M. D., Wong, C., Lin, K., Streib, J. E., Dorschner, R., Leung, D. Y. M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4271 · Cited by 275
The path to a successful vaccine adjuvant – ‘The long and winding road’
O’Hagan, D. T., & De Gregorio, E. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.009 · Cited by 274
Functional Consequences of Toll-like Receptor 4 Polymorphisms
Ferwerda, B., McCall, M. B. B., Verheijen, K., Kullberg, B.-J., van der Ven, A. J. A. M., Van der Meer, J. W. M., & Netea, M. G. (2008) · Molecular Medicine · doi:10.2119/2007-00135.ferwerda · Cited by 260
Dubensky, T. W., & Reed, S. G. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.04.007 · Cited by 259
A linguistic model for the rational design of antimicrobial peptides
Loose, C., Jensen, K., Rigoutsos, I., & Stephanopoulos, G. (2006) · Nature · doi:10.1038/nature05233 · Cited by 247
Kinnebrew, M. A., Ubeda, C., Zenewicz, L. A., Smith, N., Flavell, R. A., & Pamer, E. G. (2010) · The Journal of Infectious Diseases · doi:10.1086/650203 · Cited by 236
Unleashing the therapeutic potential of NOD-like receptors
Geddes, K., Magalhães, J. G., & Girardin, S. E. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2783 · Cited by 232
Tidswell, M., Tillis, W., LaRosa, S. P., Lynn, M., Wittek, A. E., Kao, R., Wheeler, J., Gogate, J., & Opal, S. M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b07b78 · Cited by 229
Bacterial c-di-GMP Is an Immunostimulatory Molecule
Karaolis, D. K. R., Means, T. K., Yang, D., Takahashi, M., Yoshimura, T., Muraille, E., Philpott, D., Schroeder, J. T., Hyodo, M., Hayakawa, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2171 · Cited by 222
Self-citationNijnik, A., Madera, L., Ma, S., Waldbrook, M., Elliott, M. R., Easton, D. M., Mayer, M. L., Mullaly, S. C., Kindrachuk, J., Jenssen, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901813 · Cited by 216
Self-citationPotential of immunomodulatory host defense peptides as novel anti-infectives
Easton, D. M., Nijnik, A., Mayer, M. L., & Hancock, R. E. W. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.004 · Cited by 215
Self-citationProbiotics for the treatment of bacterial vaginosis
Senok, A. C., Verstraelen, H., Temmerman, M., & Botta, G. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006289.pub2 · Cited by 189
Teplitski, M., Mathesius, U., & Rumbaugh, K. P. (2011) · Chemical Reviews · doi:10.1021/cr100045m · Cited by 180
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
Barochia, A., Solomon, S., Cui, X., Natanson, C., & Eichacker, P. Q. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.558190 · Cited by 169
Mucosal Administration of Flagellin Protects Mice from Streptococcus pneumoniae Lung Infection
Muñoz‐Wolf, N., Maele, L. V., Marqués, J. M., Rial, A., Sirard, J., & Chabalgoity, J. A. (2010) · Infection and Immunity · doi:10.1128/iai.00224-10 · Cited by 165
Probiotics and oral health effects in children
Twetman, S. H. A., & STECKSÉN‐BLICKS, C. (2007) · International Journal of Paediatric Dentistry · doi:10.1111/j.1365-263x.2007.00885.x · Cited by 160
The advent of the cytokine storm
Clark, I. A. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100062 · Cited by 159
Ungaro, R., Fukata, M., Hsu, D., Hernandez, Y., Breglio, K., Chen, A., Xu, R., Sotolongo, J., Espana, C., Zaias, J., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90496.2008 · Cited by 159
Mathematical models of vaccination
Scherer, A., & McLean, A. (2002) · British Medical Bulletin · doi:10.1093/bmb/62.1.187 · Cited by 159
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses
Schellack, C., Prinz, K., Egyed, A., Fritz, J. H., Wittmann, B., Ginzler, M., Swatosch, G., Zauner, W., Kast, C., Akira, S., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.071 · Cited by 158
Human beta‐defensin‐3 promotes wound healing in infected diabetic wounds
Hirsch, T., Spielmann, M., Zuhaili, B., Fossum, M., Metzig, M. O., Koehler, T., Steinau, H., Yao, F., Onderdonk, A. B., Steinstraesser, L., et al. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1287 · Cited by 156
Smyth, A. R., Cifelli, P., Ortori, C. A., Righetti, K., Lewis, S., Erskine, P., Holland, E. D., Givskov, M., Williams, P. M., Cámara, M., et al. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21193 · Cited by 141
Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis
Sorbara, M. T., & Philpott, D. J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01047.x · Cited by 140
Self-citationBis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
Ebensen, T., Libanova, R., Schulze, K., Yevsa, T., Morr, M., & Guzmán, C. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.026 · Cited by 137
Stimulated Innate Resistance of Lung Epithelium Protects Mice Broadly against Bacteria and Fungi
Evans, S. E., Scott, B. L., Clement, C. G., Larson, D. T., Kontoyiannis, D., Lewis, R. E., LaSala, P. R., Pawlik, J., Peterson, J. W., Chopra, A. K., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0260oc · Cited by 129
Enabling a systems biology approach to immunology: focus on innate immunity
Gardy, J. L., Lynn, D. J., Brinkman, F. S. L., & Hancock, R. E. W. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.03.009 · Cited by 126
Self-citationFischer, P. (2003) · Current Protein & Peptide Science · doi:10.2174/1389203033487054 · Cited by 123
van Dissel, J. T., Soonawala, D., Joosten, S. A., Prins, C., Arend, S. M., Bang, P. F., Tingskov, P. N., Lingnau, K., Nouta, J., Hoff, S. T., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.135 · Cited by 122
Kim, Y., Park, J., Reimer, T., Baker, D. P., Kawai, T., Kumar, H., Akira, S., Wobus, C. E., & Núñez, G. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.05.006 · Cited by 121
Stimulation of Lung Innate Immunity Protects against Lethal Pneumococcal Pneumonia in Mice
Clement, C. G., Evans, S. E., Evans, C. M., Hawke, D. H., Kobayashi, R., Reynolds, P. R., Moghaddam, S. J., Scott, B. L., Melicoff, E., Adachi, R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-1038oc · Cited by 121
Yu, F. X., Cornicelli, M. D., Kovach, M. A., Newstead, M. W., Zeng, X., Kumar, A., Gao, N., Yoon, S. G., Gallo, R. L., & Standiford, T. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000509 · Cited by 117
Small Molecules That Modulate Quorum Sensing and Control Virulence inPseudomonas aeruginosa
Mattmann, M. E., & Blackwell, H. E. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo101237e · Cited by 114
Miyairi, S., Tateda, K., Fuse, E. T., Ueda, C., Saito, H., Takabatake, T., Ishii, Y., Horikawa, M., Ishiguro, M., Standiford, T. J., et al. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46658-0 · Cited by 112
Immunomodulators as adjuvants for vaccines and antimicrobial therapy
Nicholls, E. F., Madera, L., & Hancock, R. E. W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05787.x · Cited by 111
Self-citationHuman Cathelicidin Peptide LL-37 Modulates the Effects of IFN-γ on APCs
Nijnik, A., Pistolic, J., Wyatt, A. W., Tam, S., & Hancock, R. E. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901491 · Cited by 110
Self-citationAugmented Lung Inflammation Protects against Influenza A Pneumonia
Tuvim, M. J., Evans, S. E., Clement, C. G., Dickey, B. F., & Gilbert, B. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004176 · Cited by 109
Karaolis, D. K. R., Cheng, K., Lipsky, M., Elnabawi, A., Catalano, J. G., Hyodo, M., Hayakawa, Y., & Raufman, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.093 · Cited by 104
The controversial relationship between NLRP3, alum, danger signals and the next‐generation adjuvants
Spreafico, R., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2010) · European Journal of Immunology · doi:10.1002/eji.200940039 · Cited by 101
QSAR modeling and computer‐aided design of antimicrobial peptides
Jenssen, H., Fjell, C. D., Cherkasov, A. R., & Hancock, R. E. W. (2007) · Journal of Peptide Science · doi:10.1002/psc.908 · Cited by 100
Self-citationThe potential of 3′,5′-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant
Chen, W., KuoLee, R., & Yan, H. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.081 · Cited by 88
Novel anti-infectives: is host defence the answer?
Hamill, P., Brown, K. L., Jenssen, H., & Hancock, R. E. W. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.006 · Cited by 87
Self-citationMagalhaes, J. G., Rubino, S. J., Travassos, L. H., Bourhis, L. L., Duan, W., Sellge, G., Geddes, K., Reardon, C., Lechmann, M., Carneiro, L. A. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015063108 · Cited by 83
Self-citationKindrachuk, J., Jenssen, H., Elliott, M. R., Townsend, R., Nijnik, A., Lee, S. F., Gerdts, V., Babiuk, L. A., Halperin, S. A., & Hancock, R. E. W. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.094 · Cited by 80
Self-citationInhibition of RIP2/RICK/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK
Argast, G. M., Fausto, N., & Campbell, J. S. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3701-0 · Cited by 75
MINE, Y., Yokota, Y., Wakai, Y., FUKADA, S., Nishida, M., Gotô, S., & Kuwahara, S. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.1045 · Cited by 66
Mayer, M. L., Sheridan, J. A., Blohmke, C. J., Turvey, S. E., & Hancock, R. E. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016246 · Cited by 64
Self-citationShinya, K., Okamura, T., Sueta, S., Kasai, N., Tanaka, M., Ginting, T. E., Makino, A., Eisfeld, A. J., & Kawaoka, Y. (2011) · Virology Journal · doi:10.1186/1743-422x-8-97 · Cited by 64
Hafez, M., Hayes, K. S., Goldrick, M., Warhurst, G., Grencis, R. K., & Roberts, I. S. (2009) · Infection and Immunity · doi:10.1128/iai.00040-09 · Cited by 64
Nod-like receptors in intestinal homeostasis, inflammation, and cancer
Werts, C., Rubino, S. J., Ling, A., Girardin, S. E., & Philpott, D. J. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411183 · Cited by 61
Self-citationBourhis, L. L., Magalhaes, J. G., Selvanantham, T., Travassos, L. H., Geddes, K., Fritz, J. H., Viala, J., Tedin, K., Girardin, S. E., & Philpott, D. J. (2009) · Infection and Immunity · doi:10.1128/iai.01067-09 · Cited by 49
Self-citationKhajanchi, B. K., Kirtley, M. L., Brackman, S. M., & Chopra, A. K. (2011) · Infection and Immunity · doi:10.1128/iai.00096-11 · Cited by 47
CpG Oligonucleotides Improve the Protective Immune Response Induced by the Licensed Anthrax Vaccine
Klinman, D. M., Xie, H., & Ivins, B. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.030 · Cited by 45
Bourhis, L. L., Magalhaes, J. G., Selvanantham, T., Travassos, L. H., Geddes, K., Fritz, J. H., Viala, J., Tedin, K., Girardin, S. E., & Philpott, D. J. (2009) · Infection and Immunity · doi:10.1128/iai.00519-09 · Cited by 44
Self-citationTreatment of infectious diseases with immunostimulatory oligodeoxynucleotides containing CpG motifs
Dittmer, U., & Olbrich, A. R. M. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.09.007 · Cited by 34
Ireland, R., Olivares-Zavaleta, N., Warawa, J. M., Gherardini, F. C., Jarrett, C. O., Hinnebusch, B. J., Belisle, J. T., Fairman, J., & Bosio, C. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000921 · Cited by 26
Emerging drugs for the treatment of ulcerative colitis
Pastorelli, L., Pizarro, T. T., Cominelli, F., & Vecchi, M. L. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903146882 · Cited by 26
Efficacy of a polyvalent bacterial lysate in children with recurrent respiratory tract infections
Sb, R., Ruah, C. B., van Aubel, A., Abel, S., & Elsasser, U. (2001) · Advances in Therapy · doi:10.1007/bf02850109 · Cited by 24
Yang, Y., Zhao, W., Xia, H., Zhong, Y.-D., Huang, P. C., & Wen, J. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.023 · Cited by 18
Cited by
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295
Self-citationKumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Self-citation
Metadata
- Authors
- Hancock, R. E. W., Nijnik, A., & Philpott, D. J.
- Venue
- Nature Reviews Microbiology
- Published
- 2012-03-16
- Volume
- 10
- Issue
- 4
- Pages
- 243-254
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1992542859
- Cited by
- 535
- References
- 114
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.